Physician profile
Robert E Miller
NPI 1962552323
$3,027.95
in general payments reported to CMS, 2019-2025
13 companies · $93.54 in 2025
The $93.54 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $55.37 · 2021: $249 · 2022: $317 · 2023: $261 · 2024: $394 · 2025: $93.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437 · Travel and Lodging: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.91 |
| Travel and Lodging | $311.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,800.97 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $393.56 | 2024 | Venaseal |
| Smith+Nephew, INC. | $233.39 | 2021-2022 | |
| Davol INC. | $144.23 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $98.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $89.14 | 2021 | |
| Kci USA, INC. | $82.43 | 2019 | |
| Prytime Medical Devices, INC. | $74.83 | 2025 | Er-Reboa Plus |
| Innovation Technologies INC | $44.26 | 2020 | |
| Amgen INC. | $23.90 | 2023 | Amjevita |
| Vertex Pharmaceuticals Incorporated | $18.71 | 2025 | |
| Janssen Biotech, INC. | $12.72 | 2019 | |
| Olympus America INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.